BDMD Baird Medical Investment Holdings Limited
Healthcare$1.63-0.61%ClosedMarket Cap: $66.8M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
6.93
PEG
—
P/B
1.50
P/S
2.96
EV/EBITDA
-3.55
DCF Value
$2.51
FCF Yield
-2.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
83.8%
Operating Margin
-113.7%
Net Margin
-121.0%
ROE
-81.5%
ROA
-39.1%
ROIC
-50.7%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 null | $14.6M | $-16.0M | $— |
| FY null | $22.5M | $-27.3M | $— |
| Q2 null | $8.0M | $-11.3M | $— |
| Q4 null | $23.9M | $8.1M | $— |
Trading Activity
Insider Trades
View AllXu Lijiandirector
SellTue Apr 21
Qiu Quandirector:
SellTue Apr 21
Lu Rongjianofficer
SellTue Apr 21
Bilciu-Wolfson Gabrielledirector
SellFri Apr 17
Li Jie Claraofficer
SellWed Apr 15
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
CN
Exchange
—
Beta
-1.19
Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.